nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A perspective on hyperlipidemia: concepts of management in the prevention of coronary artery disease
|
Amsterdam, Ezra A. |
|
1998 |
105 |
1S1 |
p. 69S-74S nvt p. |
artikel |
2 |
Benefit of aggressive lipid-lowering therapy: insights from the post coronary artery bypass graft study and other trials
|
White, Carl W |
|
1998 |
105 |
1S1 |
p. 63S-68S nvt p. |
artikel |
3 |
Cardiovascular risk continuum: implications of insulin resistance and diabetes
|
Hsueh, Willa A. |
|
1998 |
105 |
1S1 |
p. 4S-14S nvt p. |
artikel |
4 |
Endothelial function in health and disease: new insights into the genesis of cardiovascular disease
|
Quyyumi, Arshed A. |
|
1998 |
105 |
1S1 |
p. 32S-39S nvt p. |
artikel |
5 |
Epidemiologic aspects of lipid abnormalities
|
Criqui, Michael H |
|
1998 |
105 |
1S1 |
p. 48S-57S nvt p. |
artikel |
6 |
Evolution of angiotensin-converting enzyme inhibition in hypertension, heart failure, and vascular protection
|
Parmley, William W |
|
1998 |
105 |
1S1 |
p. 27S-31S nvt p. |
artikel |
7 |
Role of angiotensin-converting enzyme inhibition in reversal of endothelial dysfunction in coronary artery disease
|
Mancini, G.B.John |
|
1998 |
105 |
1S1 |
p. 40S-47S nvt p. |
artikel |
8 |
The American College of Physicians guidelines for screening blood cholesterol levels: a commentary
|
Criqui, Michael H. |
|
1998 |
105 |
1S1 |
p. 75S-76S nvt p. |
artikel |
9 |
The cardiovascular dysmetabolic syndrome
|
Fagan, Timothy C |
|
1998 |
105 |
1S1 |
p. 77S-82S nvt p. |
artikel |
10 |
The deadly quartet revisited
|
Deedwania, Prakash C. |
|
1998 |
105 |
1S1 |
p. 1S-3S nvt p. |
artikel |
11 |
The new diagnostic criteria for diabetes: the impact on management of diabetes and macrovascular risk factors
|
Peters, Anne L |
|
1998 |
105 |
1S1 |
p. 15S-19S nvt p. |
artikel |
12 |
Triglycerides and atherogenic lipoproteins: rationale for lipid management
|
Krauss, Ronald M. |
|
1998 |
105 |
1S1 |
p. 58S-62S nvt p. |
artikel |
13 |
Type 2 diabetes care: the role of insulin-sensitizing agents and practical implications for cardiovascular disease prevention
|
Henry, Robert R. |
|
1998 |
105 |
1S1 |
p. 20S-26S nvt p. |
artikel |